• Autoantibodies against PTM proteins as biomarkers for lupus

  • Jan 13 2023
  • Duración: 10 m
  • Podcast

Autoantibodies against PTM proteins as biomarkers for lupus  Por  arte de portada

Autoantibodies against PTM proteins as biomarkers for lupus

  • Resumen

  • Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen social media advisor Caroline Ospelt. Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079

    Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864

    Más Menos

Lo que los oyentes dicen sobre Autoantibodies against PTM proteins as biomarkers for lupus

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.